English
Home > Products > 357-08-4

China 357-08-4 Factory

We take "customer-friendly, quality-oriented, integrative, innovative" as objectives. "Truth and honesty" is our management ideal for 357-08-4,CAS NO 357-08-4,Naloxone API,Naloxone, Make sure you you should not hesitate to call us should you be fascinated in our products. We firmly imagine our merchandise will make you pleased.
357-08-4, We care about every steps of our services, from factory selection, product development & design, price negotiation, inspection, shipping to aftermarket. We have implemented a strict and complete quality control system, which ensures that each product can meet quality requirements of customers. Besides, all of our products have been strictly inspected before shipment. Your Success, Our Glory: Our aim is to help customers realize their goals. We are making great efforts to achieve this win-win situation and sincerely welcome you to join us.

Related Products

Hot Products

  • Diethyl diethylmalonate

    Diethyl diethylmalonate

    Product Name:Diethyl diethylmalonate
    Molecular Formula:C11H20O4
    Molecular Weight:216.27
    CAS Registry Number:77-25-8
  • Givosiran

    Givosiran

    Product Name:Givosiran
    Molecular Formula:C78H139N11O30
    Molecular Weight;1710.994
    CAS Registry Number;1639325-43-1
  • Lornoxicam

    Lornoxicam

    Product Name:Lornoxicam
    Molecular Formula:C13H10ClN3O4S2
    Molecular Weight;371.82
    CAS Registry Number;70374-39-9
  • 7-Ethyl-10-hydroxycamptothecin

    7-Ethyl-10-hydroxycamptothecin

    Product Name:7-Ethyl-10-hydroxycamptothecin
    Molecular Formula:C22H20N2O5
    Molecular Weight:392.4
    CAS Registry Number:86639-52-3
  • Norandrostenedione

    Norandrostenedione

    Product Name:Norandrostenedione
    Molecular Formula:C18H24O2
    Molecular Weight:272.38
    CAS Registry Number:734-32-7
  • 1-Chlorododecane

    1-Chlorododecane

    Product Name:1-Chlorododecane
    Molecular Formula:C12H25Cl
    Molecular Weight:204.78
    CAS Registry Number:112-52-7
  • Related Blog
  • Reviews

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • What Is Misoprostol Used For?

    Misoprostol, a derivative of prostaglandin E1, can be used in the treatment of duodenal ulcer, the prevention of anti-inflammatory induced peptic ulcer and the prevention of early pregnancy.It has the function of inhibiting the secretion of gastric acid and preventing the formation of ulcer, thus protecting the gastric mucosa...

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

CAS NO 357-08-4

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept